Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CCBN (Corporate Communications Broadcast Network) was a leading provider of specialized web-based solutions for the investment community, particularly focused on investor relations (IR) and corporate communications. While not a traditional drug-development biotech, the company was a critical infrastructure provider for the life sciences and healthcare sectors, facilitating regulatory compliance, earnings webcasts, and investor disclosure for hundreds of public pharmaceutical and biotechnology firms. The company's platform allowed healthcare executives to communicate clinical trial results and financial performance to global stakeholders through integrated web environments. CCBN was acquired by Thomson Financial (now part of LSEG/Thomson Reuters) in 2004 to bolster its suite of corporate workflow tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CCBN.